Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis

Stopped The study was terminated prematurely due to the COVID-19 pandemic creating uncertainty impacting trial progress and costs.

Conditions

• Osteoarthritis of the Shoulder
• Adhesive Capsulitis

Interventions

• DRUG: FX006
• DRUG: Normal Saline

Sponsor

Pacira Pharmaceuticals, Inc

Collaborators

• [object Object]